These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8181192)

  • 1. Omeprazole-induced increase in the absorption of bismuth from tripotassium dicitrato bismuthate.
    Treiber G; Walker S; Klotz U
    Clin Pharmacol Ther; 1994 May; 55(5):486-91. PubMed ID: 8181192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tripotassium dicitrato bismuthate: absorption and urinary excretion of bismuth in patients with normal and impaired renal function.
    Treiber G; Gladziwa U; Ittel TH; Walker S; Schweinsberg F; Klotz U
    Aliment Pharmacol Ther; 1991 Oct; 5(5):491-502. PubMed ID: 1793780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of plasma bismuth levels after oral dosing with basic bismuth carbonate or tripotassium dicitrato bismuthate.
    Madaus S; Schulte-Frohlinde E; Scherer C; Kämmereit A; Schusdziarra V; Classen M
    Aliment Pharmacol Ther; 1992 Apr; 6(2):241-9. PubMed ID: 1288519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).
    Lacey LF; Frazer NM; Keene ON; Smith JT
    Eur J Clin Pharmacol; 1994; 47(2):177-80. PubMed ID: 7859806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate.
    Stables R; Campbell CJ; Clayton NM; Clitherow JW; Grinham CJ; McColm AA; McLaren A; Trevethick MA
    Aliment Pharmacol Ther; 1993 Jun; 7(3):237-46. PubMed ID: 8364129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole, amoxicillin and bismuth for peptic ulcer healing and Helicobacter pylori eradication.
    Treiber G; Walker S; Klotz U
    Arzneimittelforschung; 1997 Jan; 47(1):47-50. PubMed ID: 9037444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate.
    Nwokolo CU; Gavey CJ; Smith JT; Pounder RE
    Aliment Pharmacol Ther; 1989 Feb; 3(1):29-39. PubMed ID: 2491456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.
    Hamilton I; Worsley BW; O'Connor HJ; Axon AT
    Gut; 1983 Dec; 24(12):1148-51. PubMed ID: 6357964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of histamine H2-receptor blockade on bismuth absorption from three ulcer-healing compounds.
    Nwokolo CU; Prewett EJ; Sawyerr AM; Hudson M; Pounder RE
    Gastroenterology; 1991 Oct; 101(4):889-94. PubMed ID: 1889712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of tripotassium dicitrato bismuthate on the rat stomach.
    Waldum HL; Qvigstad G; Mårvik R; Brenna E; Syversen U; Sandvik AK
    Aliment Pharmacol Ther; 1994 Aug; 8(4):425-31. PubMed ID: 7527257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori: treatment with combinations of pivampicillin and tripotassium dicitrato bismuthate.
    Weil J; Bell GD; Powell K; Morden A; Harrison G; Gant PW; Trowell JE; Burridge S
    Aliment Pharmacol Ther; 1991 Oct; 5(5):543-7. PubMed ID: 1793785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat.
    Koo J; Ho J; Lam SK; Wong J; Ong GB
    Gastroenterology; 1982 May; 82(5 Pt 1):864-70. PubMed ID: 7060908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel means of comparing the bioequivalence of two formulations of tripotassium dicitrato bismuthate (De-Noltab).
    Coghill SB; Shepherd AN
    Postgrad Med J; 1988 Oct; 64(756):761-3. PubMed ID: 3255916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the absorption and excretion of tripotassium dicitrato-bismuthate in man.
    Lee SP
    Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):359-64. PubMed ID: 7335960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption and elimination of bismuth from oral doses of tripotassium dicitrato bismuthate.
    Froomes PR; Wan AT; Keech AC; McNeil JJ; McLean AJ
    Eur J Clin Pharmacol; 1989; 37(5):533-6. PubMed ID: 2598996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate.
    Gavey CJ; Szeto ML; Nwokolo CU; Sercombe J; Pounder RE
    Aliment Pharmacol Ther; 1989 Feb; 3(1):21-8. PubMed ID: 2491455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-penicillamine does not increase urinary bismuth excretion in patients treated with tripotassium dicitrato bismuthate.
    Nwokolo CU; Pounder RE
    Br J Clin Pharmacol; 1990 Oct; 30(4):648-50. PubMed ID: 2291879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of evidence of neurotoxicity following 8 weeks of treatment with tripotassium dicitrato bismuthate.
    Nwokolo CU; Fitzpatrick JD; Paul R; Dyal R; Smits BJ; Loft DE
    Aliment Pharmacol Ther; 1994 Feb; 8(1):45-53. PubMed ID: 8186346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic and cerebrospinal fluid accumulation of aluminium and bismuth in volunteers taking short course anti-ulcer therapy.
    Gane E; Sutton MM; Pybus J; Hamilton I
    J Gastroenterol Hepatol; 1996 Oct; 11(10):911-5. PubMed ID: 8912126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine.
    Lam SK; Lee NW; Koo J; Hui WM; Fok KH; Ng M
    Gut; 1984 Jul; 25(7):703-6. PubMed ID: 6376292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.